Search

Your search keyword '"Mells, G"' showing total 147 results

Search Constraints

Start Over You searched for: Author "Mells, G" Remove constraint Author: "Mells, G"
147 results on '"Mells, G"'

Search Results

1. Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)]

2. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

3. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

4. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

5. Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom

6. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

7. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

8. Individualizing Care: Management Beyond Medical Therapy

11. Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison

12. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

14. Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

15. FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

17. Toward precision medicine in primary biliary cholangitis

18. Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab

19. The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility

20. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

21. Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers

22. Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis

23. Individualizing Care: Management Beyond Medical Therapy

24. Prognostic models in primary biliary cholangitis

25. A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude?

26. Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy

27. The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis

28. The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis

29. Pre-treatment risk stratification in primary biliary cholangitis: a predictive model to guide first-line combination therapy

30. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

31. The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis

35. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis

36. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis

37. Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging

40. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

41. THU-218 - Pre-treatment risk stratification in primary biliary cholangitis: a predictive model to guide first-line combination therapy

43. P1147 : Validation of an alkaline phosphatase and bilirubin response criterion as biomarker for transplant-free survival in primary biliary cirrhosis in the world's two largest cohorts

48. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid

49. The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort

50. 925 FACTORS ASSOCIATED WITH POOR OUTCOME IN PRIMARY BILIARY CIRRHOSIS

Catalog

Books, media, physical & digital resources